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Tuesday, March 3, 2009 487awithin the open-closed cycle. This reveals that the outermost transmembrane
domain is important for appropriate gating and shows a high conservation of
M4 function among members of this superfamily.
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Neurotransmitter-gated receptors play a vital role in the regulation of nocicep-
tion. In the adult CNS, the ionotropic glycine and GABA receptors are typically
inhibitory and act to silence neurons by transiently permitting inward Cl cur-
rents upon activation. However, depending on the Cl equilibrium potential,
these receptors may instead depolarize neurons. We hypothesized that targeted
expression of the a1 subunit of glycine receptor (GlyR) in peripheral sensory
neurons using a non-replicating herpes simplex virus (HSV)-based vector
might reduce nociceptive behavior upon subsequent GlyR activation by exog-
enously-applied glycine. HSV-directed expression of the human a1 subunit of
GlyR alone is sufficient to produce glycine-gated chloride currents in whole-
cell patch clamp studies of infected mammalian cells. In cultured dorsal root
ganglion neurons, expressed GlyRs are diffusely localized in the neuronal
plasma membrane. In both a formalin footpad model of inflammatory pain or
an osteosarcoma pain model, rats inoculated with the GlyR-expressing vector
(vHGlyRa1) exhibited significantly reduced nociceptive behavior following
subcutaneous injection of glycine into the footpad. This reduction in pain-re-
lated behavior was reversed following injection of the GlyR antagonist strych-
nine. Targeted expression of GlyRs and their modulation via mutagenesis and/
or exogenous application of agonists, antagonists, and allosteric modulators of-
fer a novel and potentially powerful method to alter neuronal activity. Here we
show that selective activation of HSV-directed a1 GlyR expression in periph-
eral neurons eliminates pain-related behavior in two pain models, and has the
potential to be used therapeutically for pain management.
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Simultaneous Recording Of Ligand-binding And Channel-gating On Indi-
vidual Nicotinic-acetylcholine Receptors In Living Cells
Ralf Schmauder, Davor Kosanic, Ruud Hovius, Horst Vogel.
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Simultaneously measuring both the ligand-binding and the gating of ligand-
gated ion channels will provide important novel insight in receptor and channel
function (see e.g. Edelstein et. al.). Such measurements require a fluorescently
labeled agonist as ligand, single molecule sensitive optical and electrical detec-
tion, micro-second time-resolution, and optimal alignment of the optical and
electrophysiological single-channel acquisition parts.
Here we present first results from simultaneously measurements of ligand-bind-
ing and channel gating of individual prototypical ligand-gated ion channels in
living cells, using APD-based fast confocal detection and conventional patch-
clamping in single channel mode. In order to reach a reasonable throughput of
experiments, it was essential that the sample, patch-pipette and the confocal vol-
ume could be moved independently and be aligned with micrometer precision.
We show data from nicotinic-acetylcholine receptors, expressed in HEK293
cells and fluorescently labeled epibatidine as agonist, to elucidate details of
the channel gating.
S.J. Edelstein, O. Schaad & J.P. Changeux: Biochmistry;1997; 36(45), 13755
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Functional Characteristics of alpha3beta3gamma2 and alpha1beta2-
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The GABAA receptor is a member of the cys-loop family of ligand gated ion
channels and the major mediator of neuronal inhibition. Each receptor is a pen-
tameric protein complex composed of homologous subunits, the combination of
which gives rise to numerous GABAA receptor subtypes. Within the thalamus,
two synaptic GABAA receptor isoforms predominate; the a1b2g2 channels,
which are found at the synapses of relay neurons, and the a3b3g2 channels that
are located at synapses in the reticular nucleus. We endeavoured to characterize
the kinetic properties to these two GABAA receptors. Our preliminary data sug-
gest that both receptors open to a single channel conductance level of 26 pS, ir-
respective of the GABA concentration used to elicit activity. a3b3g2 GABAA re-
ceptors, however, exhibit longer active periods (bursts) at saturating (5mM) and
low (2 mM) concentrations of GABA compared to a1b2g2 GABAA receptors.
The mean burst length and intra-burst open probability (Po) for the a3b3g2 chan-
nels was 136.75 16.8 ms and 0.845 0.05 (n ¼ 4), respectively and for thea1b2g2 channels was 87.45 12.0 ms and 0.825 0.02 (n ¼ 3), respectively,
when exposed to 5 mM GABA. At 2 mM GABA, the mean burst length and Po
for a3b3g2 channels was 25.85 4.7 ms and 0.785 0.03 (n ¼ 3), respectively
and fora1b2g2 channelswas 8.45 1.9ms and 0.735 0.02 (n¼ 3), respectively.
These measurements are consistent with the reported slower deactivation phase
of ensemble, a3b3g2 mediated synaptic currents and suggest that GABA has
a longer occupancy at a3b3g2 channels than at a1b2g2 channels.
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The nitroindoline caged amino acids are hydrolytically stable and have photo-
chemical and pharmacological properties suitable for characterising neurotrans-
mitter receptors. Although the NI andMNI - caged glutamates show no interfer-
ence in the activation of glutamate receptors at 10 mM concentration range, the
corresponding GABA and glycine NI derivatives showed evidence of binding
and interference in the amplitude and kinetics of activation at their respective re-
ceptors at 0.1mMconcentrations. Similarly interferencewithGABAergic trans-
mission by 50 mMCNB-caged GABA has also been reported. We describe here
a nitroindoline cagedGABAmodified by addition of a biphosphate on the caging
groupwith the idea that the high negative chargewill impede binding of the cage
to the GABA receptor. Experiments to test the inhibition of miniature GABA
mediated synaptic events in cerebellar molecular layer interneurons showed
much reduced inhibition, approximately 66% inhibition of amplitude at 1 mM
DPNI-GABA. However, with laser pulses of 0.1 ms at 1 mM DPNI-GABA
the 10-90% risetimes were comparable with synaptically evoked currents, indi-
cating that equilibration of the cage with the receptor is fast and interferes little
with kinetic measurements. The decline of laser evoked currents was prolonged
compared with spontaneous events suggesting that the effective volume of
GABA release in the laser spot is larger than synaptic release. The precision
of locating GABA ‘hot spots’ in the focal plane was estimated to decline 50%
in 1.75 microns, permitting detailed mapping of the distribution of receptors
over neuronal compartments. Furthermore, at 100 mM DPNI-GABA, where
there is no interference with receptor activation, photolysis localised to the
soma of Purkinje neurons or interneurones suppressed spiking with millisecond
precision, providing a useful tool for network analysis.
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Neuroactive steroids are efficacious potentiators of GABA-A receptors. Recent
work identified a site in the a1 subunit of the GABA-A receptor which is essen-
tial for potentiation by steroids. However, each receptor contains two copies of
the a1 subunit, leading to questions of whether both sites are required and
whether the sites mediate distinguishable effects. We generated subunit conca-
temers so the a1 subunits could be mutated separately, and examined conse-
quences of a mutation which removes potentiation by most neurosteroids (a1
Q241L) and a mutation which mimics the presence of bound steroid (a1
Q241W). Concatemers were expressed in Xenopus oocytes, and activation by
GABA, potentiation by neuroactive steroids and the agonist activity of the par-
tial agonist P4S were determined. When the a1 Q241L mutation is made in
both a1 subunits the EC50 for activation by GABA is shifted to higher concen-
tration and the ability of neurosteroids to potentiate responses to a low concen-
tration of GABA is lost. Conversely, when the a1 Q241W mutation is made in
both subunits the EC50 for GABA is shifted to lower concentration, the relative
ability of P4S to activate the receptor is increased and potentiation by neuroste-
roids is lost. For both, mutation of only one a1 subunit did not produce the full
effect of mutating both sites. Hence, the presence of a single wild-type site is
sufficient to mediate all effects seen in macroscopic responses. Overall, muta-
tion of the a1 subunit between the g and b subunits had a larger effect, which
might reflect a subtle difference between sites or a consequence of subunit po-
sition. The data demonstrate that at a macroscopic level the presence of a single
wild-type steroid-binding site is sufficient to mediate the responses to steroid.
Supported by grant P01 GM047969.
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The general anesthetic etomidate exerts its major clinical actions through po-
tentiation of GABAA receptor activation. GABAA receptors are pentameric,
488a Tuesday, March 3, 2009usually consisting of combinations of alpha, beta, and gamma subunits. A pho-
toreactive structural analog of etomdiate ([3H]azietomidate) labels amino acids
on transmembrane domains in both alpha (M236) and beta (M286) subunits.
This suggests the presence of two interfacial anesthetic binding sites per
GABAA receptor, consistent with receptor structural homology models based
on Torpedo nicotinic acetylcholine receptor. To further characterize the etomi-
date binding site, we have created a number of Cys substitutions within the a/
b intersubunit region and have synthesized a novel etomidate derivative, 2-
(methylsulfonyl) thio-etomidate (MTS-etomidate), designed to covalently
modify cysteines. Human GABAA receptors (a1, b2, g2L) were expressed in
Xenopus oocytes and current responses were measured using two-electrode
voltage clamp. Using pCMBS and MTSEA, we found that cysteine substitu-
tions at both a1M236 and b2M286, were accessible to modification. Cysteine
modification was also evident with pCMBS at a1L232C, one helical turn above
a1M236 in TM1. In contrast, modification by MTS-etomidate was evident only
at a1M236C, but not at b2M286C or, a1L232C. These results suggest that
MTS-etomidate orients itself in a precise conformation within its binding
pocket and acts as a highly selective structural probe, yielding information
not only about the residues with which it interacts but also about the orientation
of etomidate within the biding pocket consistent with its mechanism of action.
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Recognizing the problem of rapidly equilibrating membrane-bound proteins on
cell surfaces with activating ligands due to the water layer that tightly adheres
to the surface of spherical objects (1), we began to develop caged (2) neuro-
transmitters (3,4). A caged neurotransmitter can be equilibrated with receptors
on a cell surface before photolysis releases the neurotransmitter in the micro-
second time region (3,4). Using caged neurotransmitters in whole-cell current
recordings enables the rate constants for the opening (kop) and closing (kcl) of
the receptor channel, and thus the channel-opening equilibrium constant
(Phe1), to be measured without interference from diffusional delays or recep-
tor desensitization.
The rate constants and the channel-opening equilibrium constant of the excit-
atory nicotinic acetylcholine receptor (5) are altered in the presence of noncom-
petitive inhibitors, such as cocaine, as are those of a mutated inhibitory gamma-
aminobutyric acid (GABA) receptor (6) linked to epilepsy (7). Based on the
mechanisms of the two receptors, we developed compounds that bind with
higher affinity to the open-channel than to the closed-channel conformation of
each receptor, alleviating (8,9) the inhibition of the acetylcholine receptor and
potentiating (10) the function of a mutated GABAA receptor linked to epilepsy.
1. Landau & Lifshitz (1959) Fluid Mechanics (Pergamon, Oxford)
2. Kaplan et al. (1978) Biochemistry 17, 1929
3. Milburn et al. (1989) Biochemistry 28, 51
4. Shembekar et al. (2007) Biochemistry 46, 5479
5. Hess et al. (2000) Proc. Natl. Acad. Sci. USA 97, 13895
6. Ramakrishnan. & Hess (2004) Biochemistry 43, 7534
7. Baulac et al. (2001) Nature Genetics 28, 46
8. Hess et al. (2003) Biochemistry 42, 6106
9. Chen et al. (2004) Biochemistry 43, 10149
10. Krivoshein & Hess (2006) Biochemistry 45, 11632
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While CFTR catalyses the irreversible hydrolysis of its physiological ligand
(ATP), there is disagreement about whether CFTR channel gating is a thermally
driven process (Aleksandrov & Riordan 1998 FEBS Lett. 431:97, Csanady
et al., 2006 JGP128:509). Knowing the answer to this question is of fundamen-
tal importance to understand problems leading to CFTR functional failure in
cystic fibrosis, an inherited disease of high morbidity and mortality. Although
CFTR single channel recordings do not provide a direct measure of enzymatic
activity, they do provide an opportunity to establish the relationship between
ATP binding and hydrolysis at the nucleotide binding domains (NBDs) and
channel gating. The use of Rate Equilibrium Free Energy Relationship (RE-
FER) is a possible way to probe structural dynamics in an ion channel gating
(Auerbach, 2005 PNAS 102:1408).We use this conceptual framework to reveal
the role of ATP hydrolysis in CFTR ion channel function. The REFER graphs
for the set of nucleotide ligands have slope F z1 for the openings and F z0 for the closings. This means that the nucleotide triphosphate interaction
with the binding sites is required for channel opening. In contrast, the ion chan-
nel transition from the open to the closed state occurs independently of any
events in the binding sites. This could not be interpreted by conventional me-
chanical models of molecular devices where the mobile species are levered
from the initial to the final position by force generated in the binding sites.
However this behavior fits very well to Brownian ratchet models where internal
thermal diffusion is a key element of the process, and specific interactions in-
duce no mechanical movements directly but instead are used to trap favorable
fluctuations.
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Oocytes from the Xenopus laevis toad represent an efficient expression system.
The two-electrode voltage-clamp technique (TEVC) as well as patch clamp re-
cordings from excised patches are powerful tools to study ion channels follow-
ing expression in Xenopus oocytes. The TEVC technique allows the measure-
ment of macroscopic currents from whole cells. It is widely used in basic
research and also applied for compound screening in pharmaceutical industry.
Recordings from excised patches enable the analysis of ion channels under cell
free conditions and even single channel analysis. In contrast to the TEVC tech-
nique, its application requires highly skilled electrophysiologists.
A publication by Yong Zhang et al. * describes a technique to prepare isolated
membrane vesicles from Xenopus oocytes by incubating them, after removal of
the vitelline membrane, in a hypertonic ‘‘blebbing’’ solution. This treatment in-
duces the formation of plasma membrane blebs that eventually detach from the
oocyte surface to form isolated plasma membrane vesicles (PMVs).
Here we used these PMVs to create macro patches onto a planar borosilicate
glass surface using the Port-a-Patch (Nanion) automated patch clamp device.
The PMVs formed readily gigaseals and showed small capacities as expected
for macro patches. Currents could be recorded from voltage-gated as well as
ligand-gated ion channels.
In conclusion, we present an application that has the potential to overcome the
practical limitations associated with the generation of excised patches and
might enable the automated analysis of such patches.
*Mechanically gated channel activity in cytoskeleton-deficient plasma mem-
brane blebs and vesicles from Xenopus oocytes.
Yong Zhang, Feng Gao, Vsevolod L. Popov,* Julie W. Wen,* and Owen P.
Hamill J Physiol. 2000 February 15; 523(Pt 1): 117-130.
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Determining kinetic models that describe and predict the behavior of ligand-
gated channels is a daunting task. It can be done by the analysis of a consider-
able amount of single channel recordings or, as it has recently shown for P2X2
receptors, by the analysis of macrocurrents after the application of very short
pulses of different concentrations of the agonist. Here we present some ad-
vances towards a general strategy for determining a kinetic model for any par-
ticular ligand-gated channel using ultrashort pulses. First is the problem of gen-
erating the agonist pulses. For that purpose we optimize the movement of the
liquid interface between agonist solution and saline. This movement is gener-
ated by driving a PZT actuator, whose movement is measured by the deflection
of a laser that hits a four quadrant movement detector. The movement of the
piezo was optimized to produce pulses as large as 20 micrometers and as brief
as 20 microseconds of duration. The piezo drives the movement of a theta tube
that eject the agonist and the saline, the movement of whom is measured using
stroboscopic microscopy. On the other hand, in order to achieve high speed of
solution exchange, a high velocity of fluid is necessary at the right times, so
a valve-controlled pressurized system was developed. On patch controls have
to be made by switching from saline to a low cation solution using the drop
in current as an indicator of the time profile of agonist concentration as seen
by the patch. Finally, the gathered data is analyzed by contrasting the likelihood
of different allosteric models. For that purpose, an extension of the Macro-
scopic Recursive method is presented that allow its application to time aver-
aged recordings.
